FR2701M - Médicament anti-inflammatoire, anti-oedeme et anti-thrombus, a base de bromélaine. - Google Patents

Médicament anti-inflammatoire, anti-oedeme et anti-thrombus, a base de bromélaine.

Info

Publication number
FR2701M
FR2701M FR921502A FR921502A FR2701M FR 2701 M FR2701 M FR 2701M FR 921502 A FR921502 A FR 921502A FR 921502 A FR921502 A FR 921502A FR 2701 M FR2701 M FR 2701M
Authority
FR
France
Prior art keywords
bromelain
edema
inflammatory
thrombus
thrombus drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR921502A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
William H Rorer Inc
Original Assignee
William H Rorer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William H Rorer Inc filed Critical William H Rorer Inc
Application granted granted Critical
Publication of FR2701M publication Critical patent/FR2701M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR921502A 1962-01-15 1963-01-15 Médicament anti-inflammatoire, anti-oedeme et anti-thrombus, a base de bromélaine. Expired FR2701M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US166397A US3224942A (en) 1962-01-15 1962-01-15 Anti-inflammatory, anti-edema and anti-thrombi drug

Publications (1)

Publication Number Publication Date
FR2701M true FR2701M (fr) 1964-08-03

Family

ID=22603131

Family Applications (1)

Application Number Title Priority Date Filing Date
FR921502A Expired FR2701M (fr) 1962-01-15 1963-01-15 Médicament anti-inflammatoire, anti-oedeme et anti-thrombus, a base de bromélaine.

Country Status (3)

Country Link
US (1) US3224942A (fr)
FR (1) FR2701M (fr)
GB (1) GB984464A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3280138A (en) * 1962-02-05 1966-10-18 Siegfried Ag Carbamates of benzotriazoles
GB1082206A (en) * 1963-07-02 1967-09-06 Applic Chimiques D Etudes & De Improved antibiotic medicine
FR3646M (fr) * 1964-04-06 1965-10-25 Rorer Inc William H Composition enzymatique contre la toux.
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
SE8303401D0 (sv) * 1983-06-15 1983-06-15 Pharmacia Ab Beredning och dess anvendning
EP1208849B1 (fr) * 2000-11-28 2015-10-28 URSAPHARM Arzneimittel GmbH Utilisation de la bromélaine comme thérapie adjuvante de la cicatrisation
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8916151B2 (en) 2005-04-25 2014-12-23 Cls Therapeutics Limited Method for treating a reduction of fertility
JP5372769B2 (ja) 2006-11-28 2013-12-18 シーエルエス セラピューティック リミティド 組織の細胞外間隙においてデオキシリボ核酸の量が増量することに関連するヒトの病気の治療方法及び該方法を実施するための医薬製剤
US20100310654A1 (en) * 2007-11-30 2010-12-09 Jacono Andrew A Homeopathic remedies for use before and after aesthetic injectable and surgical procedures to minimize swelling and bruising
US9707318B2 (en) * 2009-10-29 2017-07-18 Shaker A. Mousa Compositions of novel bone patch in bone and vascular regeneration
US20110104265A1 (en) * 2009-10-29 2011-05-05 Mousa Shaker A Compositions and methods of targeted nanoformulations in the management of osteoporosis
US8563053B2 (en) * 2009-10-29 2013-10-22 Shaker A. Mousa Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis
CN104784138A (zh) * 2014-01-16 2015-07-22 南京瑞尔医药有限公司 一种菠萝蛋白酶肠溶片组合物
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
US11701410B2 (en) 2015-05-22 2023-07-18 Cls Therapeutics Limited Extracellular DNA as a therapeutic target in neurodegeneration
AU2019209770B2 (en) 2018-01-16 2025-07-31 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US293073A (en) * 1884-02-05 pearoe
CA600032A (en) * 1960-06-14 J. Martin Gustav Proteolytic enzyme-antibiotic compositions
US3072532A (en) * 1958-11-04 1963-01-08 Innerfield Irving Administration of enzymic composition
US3004893A (en) * 1959-10-21 1961-10-17 Richardson Merrell Inc Enteric coated trypsin and chymotrypsin anti-inflammatory compositions

Also Published As

Publication number Publication date
GB984464A (en) 1965-02-24
US3224942A (en) 1965-12-21

Similar Documents

Publication Publication Date Title
FR2701M (fr) Médicament anti-inflammatoire, anti-oedeme et anti-thrombus, a base de bromélaine.
FR3103M (fr) Médicaments a base de dérivés alkéniques.
FR1320M (fr) Agents pharmaceutiques a base de benzenedisulfamides.
FR2526M (fr) Médicament inhibiteur de la pyrocatechol-0-méthyltransferase.
FR1704M (fr) Médicament anti-allergique et anti-histaminique a base de β-alanine.
FR1374M (fr) Médicament diurétique a base de dérivé de benzo-thiadiazine.
FR2065M (fr) Médicament a action analgésique a base de phényl-alkylamine.
FR2288M (fr) Médicament analgésique et anti-émétique, a base de 1-phényl-3-(beta-diéthylamino-éthyl)-imidazolidones-(2).
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR2367M (fr) Médicament antiphlogistique a base de diosgénine.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR3193M (fr) Nouveaux médicaments a base de dibenzocycloheptenes substitués.
FR2220M (fr) Médicament sédatif a base de dérivé de carbamate d'aryloxy-alcoyle.
FR3235M (fr) Médicament a base de sulfanilamido-pyrimidine.
FR2577M (fr) Médicament a base de naphtyl-amino-imidazoline.
FR2366M (fr) Médicament antiphlogistique a base de ruscogénine.
FR2360M (fr) Médicament antiphlogistique a base de tigogenine.
FR1013M (fr) Médicament analgésique, antithermique et antirhumatismal.
FR1864M (fr) Médicament nouveau a base de mercapto-acyl-amido-5-nitrothiazoles.
FR3033M (fr) Médicaments a base de sulfapyridines.
FR2519M (fr) Médicament analgésique.
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR2206M (fr) Médicament a base de 2.4.7-triamino ptéridine.
FR2473M (fr) Médicament a base de corticostéroides.